Shanghai Biomedical Industrial Equity Investment Fund logo

Shanghai Biomedical Industrial Equity Investment Fund

Asia, Shanghai, China, Huangpu

Description

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.

Investor Profile

Shanghai Biomedical Industrial Equity Investment Fund has backed more than 15 startups, with 6 new investments in the last 12 months alone. The firm has led 8 rounds, about 53% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in China, Hong Kong.
  • Strong thematic focus on Health Care, Medical, Pharmaceutical.
  • Led 4 rounds in the past year.

Stage Focus

  • Series A (27%)
  • Series B (27%)
  • Series C (20%)
  • Series Unknown (13%)
  • Series D (7%)
  • Angel (7%)

Country Focus

  • China (87%)
  • Hong Kong (7%)

Industry Focus

  • Health Care
  • Medical
  • Pharmaceutical
  • Biotechnology
  • Medical Device
  • Therapeutics
  • Fitness
  • Service Industry
  • Manufacturing
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shanghai Biomedical Industrial Equity Investment Fund frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
MediTrust Health
Asia, Shanghai, China, Xuhui
Co-Investments: 1
GB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 3
HC
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Co-Investments: 1
M&
North America, New York, United States, New York
Co-Investments: 1
Janchor Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

Which angels does Shanghai Biomedical Industrial Equity Investment Fund often collaborate with?

FM
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by Shanghai Biomedical Industrial Equity Investment Fund?

NeuShen Therapeutics

Shanghai, Shanghai, China

NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.

BiotechnologyMedicalNeuroscience
Series AJan 28, 2026
Fortitude Biomedicines

Waltham, Massachusetts, United States

Fortitude Biomedicines is a biotechnology company that develops antibody-based biologic drugs targeting autoimmune diseases.

BiotechnologyMedical
SeedJan 26, 2026
Amount Raised: $13,000,000
Baiyi Pharmaceutical

Hangzhou, Zhejiang, China

Baiyi Pharmaceutical is a pharmaceutical company focused on the research and development of innovative drugs for neurological diseases.

Health CarePharmaceutical
SeedJan 13, 2026
Amount Raised: $14,335,479
Surgerii Technology

Haidian, Beijing, China

Surgerii Technology is a developer of minimally invasive surgical robots.

Health CareMedicalRobotics
Series DDec 31, 2025
Amount Raised: $14,308,608
Haimai Medical

Suzhou, Jiangsu, China

Haimai Medical is a platform for tissue engineering and regenerative medicine technology.

MedicalTherapeutics
Series ADec 29, 2025
Amount Raised: $14,273,684
Anhui Qiarui Biotechnology

Hefei, Anhui, China

Anhui Qiarui Biotechnology provides Class III blood purification consumables.

BiotechnologyHealth Care
SeedNov 3, 2025
Artec Bio

Hangzhou, Zhejiang, China

Artec Bio is a developer of next-generation protein degradation drugs

Series AAug 1, 2025
Editact

Hong Kong, Hong Kong Island, Hong Kong

Editact specializes in the development of novel gene treatments for Alzheimer's disease.

Health CareTherapeutics
SeedJul 21, 2025
Easy Flow

Shanghai, Shanghai, China

Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

Health CareMedical
Series AApr 23, 2025
Amount Raised: $13,723,068
NeuShen Therapeutics

Shanghai, Shanghai, China

NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.

BiotechnologyMedical
Series AApr 18, 2025

Find More Investors Like Shanghai Biomedical Industrial Equity Investment Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Shanghai Biomedical Industrial Equity Investment Fund | Pipeseed